IGKV2D-29 and cocaine dependence: To the extent that modulation of dopamine has shown promise as a pharmacotherapy for cocaine dependence [5,72,6,4], the use of A2A antagonists may be efficacious either as adjunctive supplements to direct dopamine modulators, or as monotherapies in patients for whom direct modulators are not indicated medically or are ineffective.